These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21664676)

  • 1. The future of immunisation policy, implementation, and financing.
    Levine OS; Bloom DE; Cherian T; de Quadros C; Sow S; Wecker J; Duclos P; Greenwood B
    Lancet; 2011 Jul; 378(9789):439-48. PubMed ID: 21664676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.
    Chauke-Moagi BE; Mumba M
    Vaccine; 2012 Sep; 30 Suppl 3():C3-8. PubMed ID: 22939018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The decision making process on new vaccines introduction in South Africa.
    Ngcobo NJ; Cameron NA
    Vaccine; 2012 Sep; 30 Suppl 3():C9-13. PubMed ID: 22939028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To save children's lives, China should adopt an initiative to speed introduction of pneumonia vaccines.
    Yu H; Yang W; Varma JK
    Health Aff (Millwood); 2012 Nov; 31(11):2545-53. PubMed ID: 23129686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropical disease vaccines.
    Riddell A; Pollard AJ
    Expert Rev Vaccines; 2003 Feb; 2(1):105-12. PubMed ID: 12901602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australia's contribution to global immunisation.
    Ruff TA; Taylor K; Nolan T
    Aust N Z J Public Health; 2012 Dec; 36(6):564-9. PubMed ID: 23216498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative.
    Adjagba A; Senouci K; Biellik R; Batmunkh N; Faye PC; Durupt A; Gessner BD; da Silva A
    Vaccine; 2015 Jan; 33(5):588-95. PubMed ID: 25545597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Global immunization policies and recommendations: objectives and process].
    Duclos P; Okwo-Bele JM
    Med Sci (Paris); 2007 Apr; 23(4):409-16. PubMed ID: 17433232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global support for new vaccine implementation in middle-income countries.
    Kaddar M; Schmitt S; Makinen M; Milstien J
    Vaccine; 2013 Apr; 31 Suppl 2():B81-96. PubMed ID: 23598496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financing vaccinations - the South African experience.
    Blecher MS; Meheus F; Kollipara A; Hecht R; Cameron NA; Pillay Y; Hanna L
    Vaccine; 2012 Sep; 30 Suppl 3():C79-86. PubMed ID: 22939027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meeting the need for advocacy, social mobilisation and communication in the introduction of three new vaccines in South Africa - successes and challenges.
    Baleta AF; van den Heever J; Burnett RJ
    Vaccine; 2012 Sep; 30 Suppl 3():C66-71. PubMed ID: 22939025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of GAVI, the Global Fund and World Bank support for human resources for health in developing countries.
    Vujicic M; Weber SE; Nikolic IA; Atun R; Kumar R
    Health Policy Plan; 2012 Dec; 27(8):649-57. PubMed ID: 22333685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human vaccine research and development: an overview.
    Kieny MP; Girard MP
    Vaccine; 2005 Dec; 23(50):5705-7. PubMed ID: 16182415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial challenges of immunization: a look at GAVI.
    Kaddar M; Lydon P; Levine R
    Bull World Health Organ; 2004 Sep; 82(9):697-702. PubMed ID: 15628208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstacles to developing vaccines for the Third World.
    Robbins A; Freeman P
    Sci Am; 1988 Nov; 259(5):126-33. PubMed ID: 3212439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases.
    Commun Dis Intell Q Rep; 2004; 28(1):92-5. PubMed ID: 15072163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.